text:
Serrano Ham and Manchego Croquetas with Smoked Pimentón Aioli
If you like it, save it!
Save and organize all of the stuff you love in one place.Got it!
If you like something…
Click the heart, it's called favoriting. Favorite the stuff you like.Got it!
Author Notes: My husband and I celebrated our anniversary last year by taking a wonderful trip to Spain. Although we tried a countless number of tapas, our favorite was the croquetas- Spanish croquettes filled with different ingredients. My croquetas use classic Spanish ingredients like salty Serrano ham and nutty Manchego cheese. And to serve with them, I make an aioli using Pimenton de La Vera, a delicious sweet smoked paprika. You may want to make extra croquetas because your guests will gobble them up! —Sonali aka the Foodie Physician
Food52 Review: We always love hors d'oeuvres that can be made ahead and fried up quickly for a party, and these addictive Spanish croquetas fit the bill. The cheesy, ham-flecked dough is a cross between a choux (without the egg) and a floury bechamel. Once it cools and thickens up, you can put little (or big) helpers on ball-rolling duty. The crust fries up shaggy and golden from the panko, and the paprika aioli is pretty in pink, with an assertive garlic punch. - A&M —The Editors
Makes 20-22
Serrano Ham and Manchego Croquetas
- 2 tablespoons extra virgin olive oil
- 3 tablespoons unsalted butter
- 1/2 cup all purpose flour
- 1 1/4 cups whole milk
- 1/3 cup finely chopped Serrano ham (can substitute prosciutto), about 1.8 oz
- 1/3 cup grated Manchego cheese, about 1.8 oz
- 1/8 teaspoon grated nutmeg
- Kosher salt
- 2 eggs
- 1 cup panko breadcrumbs
- Vegetable oil for frying
Smoked Pimenton Aioli
- 1 cup mayonnaise
- 2 cloves garlic
- 2 teaspoons fresh lemon juice
- 1 teaspoon Spanish sweet smoked paprika such as Pimentón de La Vera
- Heat the oil and butter in a medium saucepan over medium heat until butter is melted. Add the flour and cook 1-2 minutes while whisking frequently. Gradually add the milk while whisking and continue to cook another 2-3 minutes. The mixture should be smooth. Switch to a wooden spoon and stir in the ham, cheese and nutmeg. Cook another 1-2 minutes while stirring- the mixture will pull away from the sides of the pan. Taste the mixture and add salt if desired- the ham and cheese are salty so you probably won't need to add any additional salt.
- Transfer the mixture to an 8x8-inch baking tray and spread it out so that it is even. Let the mixture cool, then cover it with plastic wrap and refrigerate at least 2 hours or overnight.
- When ready to cook the croquetas, lightly beat the eggs in a shallow dish. Mix the breadcrumbs and ½ teaspoon salt in another dish. Scoop up tablespoons of the cooled filling and form them into balls. Dip each ball into the egg and then the breadcrumbs. Place the completed croquetas on a wire rack or baking sheet and refrigerate for 20 minutes. The croquetas must be chilled before frying otherwise they may fall apart in the oil.
- Meanwhile, make the aioli by pureeing the mayonnaise, garlic, lemon juice, and smoked pimentón in a blender or mini food processor. Transfer to a small bowl and refrigerate until ready to serve.
- Pour enough vegetable oil into a large stockpot to reach a depth of 1 inch and heat over medium high heat. Working in batches, fry the croquetas in the oil, turning them on all sides, until golden brown and crispy, about 2 minutes. Drain on paper towels. Serve immediately with the smoked pimentón aioli.
- Your Best One-Bite Party Snack Contest Winner!
More Great Recipes: Snacks|Pork|Appetizers|Hors d'oeuvres|Olive Oil
Topics: Holiday Entertaining
This Week's Best #F52Farmstands
Cheese peppers, grapes, and more
This week's best #F52farmstands.
Get baking this Labor Day.
Meet 2015's best sellers.
Make these recipes before it's too late.
Storage made crystal clear.
Comments (79) Questions (5)
4 months ago Sue
My guests loved and the Aioli is going to be a staple in my refrigerator. I expected more of a bread texture than dough. Wondered if I over stirred. Regardless, will make again and think will just make smaller croquetas so that I have more crisp on each bite.
4 months ago Sonali aka the Foodie Physician
So glad you liked them! It doesn't sound like you over-stirred- the texture of the filling should be soft and creamy, not breadlike.
over 1 year ago Amber
Divine! I have another recipe for Serrano and Manchengo croquetas from Jose Garces but his recipe is so much more complicated and intimidating than this. Thank you for making my life easier!
over 1 year ago Sunny Aalami
This recipe is amazing! Serive with lime.
over 1 year ago Miguel Rossello
Espectacular... You should also try sobrasada (sausage from Mallorca) with Mahones cheese croquetas... With tomato jam...
over 1 year ago The Tasty Word
Oh, I second the idea of using sobrasada. My mother's family is from Mallorca, but we live in Panama, and the most anticipated treats from when someone in the family travels there is when they bring back sobrasada and ensaimada.
over 1 year ago Joseph Hamby
Another wonderful recipe, Doc...definitely on-point!
over 1 year ago Amy
I wanted to love these, but just didn't :( I made them on Christmas morning to take to an afternoon family get together, but I fried up a couple, tried one for the first time, and had to leave them behind. The texture was very unappetizing, and the flavor just didn't do it for me. Didn't try the sauce...
over 1 year ago Irma Davidson
Thank you very much Sonali. I just made them last night as an appetizer for my 7 year old granddaughter and she loved them. She asked me to make them and take them warm for her school lunch next Wednesday and Christmas appetizers.
almost 2 years ago procrastibaker
These are AMAZING. I made them as an appetizer for Thanksgiving, and it's all we can do not to eat all of them before we head to our official dinner. Having the oil at 350F helps avoid the oozing, although I still had to carefully watch them. A few of them split, but they stayed together enough to transport. Delicious. I'll certainly be making these again.
almost 2 years ago keg72
Great recipe! For those who've had the oozing problem, I might know the issue. Make sure your oil is hot enough. I had mine down around 325 because I like the look of the blonder color. But, they all oozed. When I got the oil up to 350, using the same batch of formed croquetas, no oozing. (And I also didn't have the oozing problem the first time I made these at 350.) Also, I just wanted to note that I froze fully cooked croquetas and then baked them, from frozen, at 350 for 15-20 minutes, and they were as good as they were when fresh. Finally, this time I added a few TBS of minced onion, and it really increased the flavorfulness. Hope that helps someone!
over 2 years ago Mel Mercedes
Such a great recipe! I lived in Southern Spain for half a year and ordered croquetas everywhere I went...at least 3 times a week! These are just as good if not better than most I tried. Thanks for sharing :)
over 2 years ago sansan123
Thank You. Made the mistake of sending my darling hub to the supermarche wihout adult supervision. e returned with a whopping big serrano ham and I have been trying to find things to do with it. This looks perfect,though I will substitute the machengo as he doesn't like it.
over 2 years ago Nela
I made these over the Holidays and they were delicious. Please keep in mind that once you make the bechamel you must refrigerate in a baking pan for at least 2 hours prior to shaping the croquetas and refrigerate again for another 30 minutes before you can finish them. So I would recomend to start them a day ahead so all you have to is fry them and serve just before you are going to serve them. They are delicious and very filling. Just like the ones in Spain.
over 2 years ago Urbain Dubois
Thanks so much for this recipe and the step by step images for preparation. I have not tried it but I am certain these are addictive!
over 2 years ago Urbain Dubois
What is the difference between Spanish and Hungarian paprika? I just purchased a large, beautifully decorated can of hot Hungarian paprika. As infrequently as I use paprika it is way too much but couldn't resist.
over 2 years ago ELISER
if you need any of this ingredients, you can buy here;
Spanish Food Online; www.ladespensashop.com
over 2 years ago htan
I made these the other day for my baby shower. Unfortunately they also exploded like another reviewer said (In the question portion). I even measured/weighed out the cheese because it was thought that too much cheese would make that happen. Disappointed in the results, I couldn't even serve any of them, 2/3 of them had the cheese ooze out into my oil. I wonder what the problem was?
over 2 years ago Sonali aka the Foodie Physician
I'm sorry to hear that! I think the most common reason for them exploding would be that they're not chilled enough. Did you refrigerate them for several hours to firm up the mixture before frying? Also, if you were frying them for too long or if the oil was too hot, that could have caused the problem. Finally, perhaps they weren't coated with enough breadcrumbs. Sometimes I crush the panko very finely to ensure an even crust.
almost 3 years ago Frankiefurt
Hi, I'm from Spain and, although this ones are great and are one of my favourites, here we have croquetas of almost everything. You can change the ham for boiled chicken, or for boiled codfish, or for boiled Spinachs or for boiled Shrimps. And we don't usually eat them with ali-oli. Ali-oli goes great with Fideuá, cuttlefish, Paella, etc. And the real Ali-Oli is just garlic and olive oil, but it's really difficult to make it. It requires a great patience and technique. We also usually do it with mayonnaise. ¡Hasta luego!
almost 3 years ago blanka.n
I have been dying to make these,
almost 3 years ago Sonali aka the Foodie Physician
Thanks, I hope you like them!
over 3 years ago DIANELLY
this looks delocius and I will try to do it today. Can I change the sweet paprika for hot paprika? is so, how much should I put? thank you
almost 3 years ago Sonali aka the Foodie Physician
Yes, you can substitute sweet paprika. I would start with the same amount and then adjust to taste.
over 3 years ago LE BEC FIN
hi sonali,want to thank you for this terrific recipe.You would have had me at Crunchy, but Gooey Cheesy and I was all yours! I made them last night for dinner for the 2 of us, to accompany chowbella's terrific recipe for Citrus Chimmichuri Pork Roast , whch i adapted for turkey .I had to MAKE myself eat my salad!
I did make a few changes. I added 1/8 cup grated/ground Parm , used 1/4 teaspoon nutmeg (double yours) and , because i don't care for serrano, used Jone's Canadian bacon, my fav ham component.The parm made a huge difference and really brought together all the flavors.
I learned to pull them from the oil a little bit before I would have (because otherwise, they explode and lose their filling!)
I am new to 52 and was thrilled to have one of my citrus recipes chosen as a CP. thanks so much again and congrats on your well deserved win.


text:
Difference between revisions of "Talk:Install"
(Point out that version mentions are out of date)
|Line 65:
|Line 65:
"There are currently two versions of Nginx available: stable (1.2.x), development (1.3.x)." — should be 1.4.x and 1.5.x, respectively.
"There are currently two versions of Nginx available: stable (1.2.x), development (1.3.x)." — should be 1.4.x and 1.5.x, respectively.
[[User:Gthb|Gthb]] ([[User talk:Gthb|talk]]) 16:19, 4 July 2013 (UTC)
[[User:Gthb|Gthb]] ([[User talk:Gthb|talk]]) 16:19, 4 July 2013 (UTC)
Revision as of 18:42, 25 October 2013
How do I edit this page?
The Install page cannot be edited - probably as a spam protection measure. Add your change suggestions to the Talk page, hopefully someone will notice.
- It seemed like a bad idea to allow the download links to be publicly editable. - Cliff
- However, the Windows binary link is now several releases behind. Do we want to do something about this? Maybe link to the download page instead? - firai
French translation
- Is it possible to add a link to the french translation ? -Arhuman
There are several translations of the information on this wiki. If you can help translate into your native language, please feel free to contribute.
I'm not clear on where this would go: there's already a link to NginxFr on the main page, where all the other translations are listed. NginxFr should be linking to InstallFr.
- Cliff
@cliff Sadly, on NginxFr I can't modify the link on the top icon (which is the natural/obvious way to reach the InstallFr page)
I'll add the link on NginxFr content (even if it'll seem awkward, imnsho)
Agreed, this is not ideal. However, MediaWiki does a poor job with multi-lingual support. We've been looking into ways to address this but currently there are none that are in any way appealing. -MTeck
For the compiling from source section, there should be a mention of prerequisite libraries. On Ubuntu Natty, when I ran ./configure, the PCRE library was missing. It's not obvious which aptitude package to install, so I think it would be useful to note the correct library (libpcre++-dev). UPDATE: NginxPlatformUbuntu mentions a different library. GettingStarted has a section on installation as well. -- Dandv 19:24, 7 June 2011 (MSD)
Just FYI, the required package on Debian/Ubuntu is libpcre3-dev, not libpcre++-dev (Nginx is written in C, not C++). libpcre++-dev itself pulls in libpcre3-dev as a dependency, which in turn, satisfies the Nginx dependency.
libpcre3-dev is not the correct package for all platforms (only Debian-derived ones). On Red Hat-derived distros it's pcre-devel. On BSD it will be something else entirely. We cannot cover the exact packages names for every platform in a single section (although you are welcome to add such information to the distribution-specific page (NginxPlatformUbuntu).
Secondly, the requirements vary depending upon which compile-time options are selected.
In any case, if you are building from source, you are expected to peruse the README and INSTALL files included with the tarball. These describe the general requirements for building with the various options and are the canonical source for such information (which may change between releases).
For people unfamiliar with how to discover this information, well, that's why there are binary packages.
-- Cliff
- I see. Would it be a good idea then to not repeat the "compile from source" steps in a bunch of places, but rather link to one page (GettingStarted perhaps) that comprehensively deals with the issue? -- Dandv(talk|contribs) 21:51, 7 June 2011 (MSD)
- Yes, that would be best. The wiki is known to have lots of historical cruft that it would be better off without. For the building from source, a separate page might be appropriate, where various issues could also be addressed.
Solaris 11
Would we get Installing_on_Solaris_11 added under "Other systems" ?
- Done. cliff
Fix Ubuntu PPA install section for Ubuntu >= 12.10
Could someone please edit the Ubuntu PPA install section?
Ubuntu 12.10 doesn't have `python-software-properties` module; instead you need to install `software-properties-common`.
Out-of-date version mentions
"There are currently two versions of Nginx available: stable (1.2.x), development (1.3.x)." — should be 1.4.x and 1.5.x, respectively. Gthb (talk) 16:19, 4 July 2013 (UTC)
Still an issue. - Apeschel 25 October 2013

subset: commoncrawl


text:
The browser you are using is out of date and is no longer supported. To view and use this site correctly, please update your browser to the latest version.
18 April 2006Regeneration projects across Scotland will share more than £6 million from Historic Scotland's Historic Environment Regeneration Fund (HERF).
For further information


text:
in this issue
premium services
online directory
customer care
Regions :: North America
Chemicals sector rail traffic falls 9.8%; full-year traffic down 1.8%
2:12 PM MST | January 3, 2013 | Vincent Valk
Chemicals sector rail traffic in North America declined 9.8% year-on-year (YOY) during the week ended 29 December, to 36,228 cars, according to the Association of American Railroads (AAR; Washington). US traffic was down 7.3%, to 26,571 cars. Canadian traffic fell 18.3%, to 8,499 cars, while Mexican traffic rose 6.5%, to 1,158 cars. Traffic fell from the prior week's totals. The week included the Christmas holiday. For the year ended 29 December, the North American chemicals sector generated 2,145,166 cars of rail traffic, down 1.8% from 2011 levels...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee
contact us | about us | customer care | privacy policy | sitemap | advertise
Copyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.


text:
"I believe in the Holy Spirit"
Modern Bible translations are in the news these days, sometimes for controversial reasons. But one universal benefit of them is that the Holy Spirit is no longer referred to as "it." Curiously a chief culprit here is the much-loved King …Read More
The Wind Blows Where it Wills
Who has seen the wind?This little poem for children by Christina G. Rossetti captures at once something of the …Read More
Neither you nor I.
But when the trees bow down their heads,
The wind is passing by.
The Breath of God
Creation The ancient hymn Veni Creator Spiritus, composed in the eighth century and part of the Roman breviary of Vespers, is a hymn extolling the Holy Spirit. John Dryden's magnificent translation renders the opening lines this way: "Creator Spirit, by …Read More
"Can These Bones Live?"
It was the early spring of 1958. I had spent the entire morning hours, till noon, on my knees beside my bed. It was the most passionate prayer experience of my young Christian life. I had been converted in September …Read More
Footprints in the Sand
The Holy Spirit leaves no footprints in the sand. He is not a physical being. He has no body or form, no hands or feet. He is invisible — He cannot be seen, and He cannot be heard. He is …Read More
United in Truth
During the second half of the twentieth century, post-Christian societies throughout the world began to shout the mantra "unity is god!" In attempting to liberate themselves from the truths upon which they were established, they bound themselves to a law …Read More
Sophisticated Lady
We've all heard the horror stories. First there was the church that offered visitors a free oil change during the "service" if you would come. Then we heard of simple cash rewards. More recently a church raffled off a new …Read More
Objective Cultural Norms
For Sir Walter Scott (1771-1832), the principle of "all things to all men" was not a moral warrant for upholding cultural relativism. Instead, it was a practical mandate for upholding cultural norms. It was for him an inducement to communicate …Read More
One, Holy, Catholic, Apostolic Worship
What would you think if you went to your church Sunday morning and a child's life was sacrificed as part of the worship? What would you think if you went to church this Sunday and discovered that a religious sexual …Read More
Forever Faithful
What Christian among us has not questioned his faith in God when things are going badly in finding a job, finding that person whom God wants him to marry, dealing with family debt, or healing a broken relationship? We may …Read More
ArticlesBrowse select Tabletalk articles and columns exploring themes and topics across a spectrum of relevant issues.
- All
- Angels and Demons
- Atonement
- Basic Reformed Theology
- Irresistible Grace
- Limited Atonement
- Perseverance of the Saints
- Total Depravity
- Unconditional Election
- The Church
- Church Discipline
- Church Leadership
- Creeds and Confessions
- God
- Holiness
- Sovereignty
- Heaven and Hell
- Heresies
- The Holy Spirit
- Jesus Christ
- Cross
- Incarnation
- Resurrection
- Justification
- Last Things
- Man and Sin
- Reference
- Sacraments
- Salvation
- Faith
- Regeneration
- Scripture
- Systematic Theology
- Theological Views
- Roman Catholicism
- Music
- Apologetics
- False Teaching
- Atheism
- Book Reviews
- Children's Books
- Christian Classics
- Christianity and Culture
- Creation
- Ethics
- Fiction and Literature
- Philosophy
- Science
- Bible Figures
- Bible Interpretation
- Bibles
- Books of the Bible
- Gospels
- Covenants
- General Reference Works
- Introduction to the Bible
- Jesus' Ministry
- Life of Jesus
- New Testament
- Old Testament
- Parables
- Prophecy
- Sermon on the Mount
- Ten Commandments
- The Lord's Prayer
- Controversies in the Church
- Alcohol
- Arts
- Bible Translation
- Covenant Theology
- Creationism
- Education
- Gender-Neutral Language
- Law and Gospel
- Lordship Salvation
- New Perspective on Paul
- Politics
- Race
- Sabbath
- Spiritual Gifts
- Women in Ministry
- Marriage and Family
- Divorce
- Parenting
- Practical Theology
- Discipleship
- Evangelism and Missions
- Grief and Death
- Pastoral Ministry
- Preaching
- Worship
- Spiritual Growth
- Anxiety and Worry
- Apostasy
- Assurance
- Conscience
- Depression
- Doubt
- Fellowship
- Godliness
- Guilt
- Humility
- Joy
- Knowing God's Will
- Legalism
- Love
- Money and Stewardship
- Oaths and Vows
- Prayer
- Pride
- Repentance and Forgiveness
- Sanctification and Growth
- Service
- Spiritual Fruit
- Suffering
- Thankfulness
- Vocation
- American Church History
- Ancient Church
- Biography
- The Byzantine East
- Eighteenth Century
- Enlightenment and Modernism
- Historical Theology
- Medieval Church
- Nineteenth Century
- Puritanism
- Reformation
- Seventeenth Century
- Twentieth Century


text:
Available Clinical Trials
To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724). E-mail: email@example.com
(NRG/COG ARST1321) Pazopanib Neoadjuvant Trial in Non-Rhabdomyosarcoma Soft Tissue Sarcomas (PAZNTIS): A Phase II/III Randomized Trial of Preoperative Chemoradiation or Preoperative Radiation Plus or Minus Pazopanib (NSC# 737754, IND# 118613)Principal Investigator: Salerno, Kilian E
(UPCC 14153) A Randomized Phase II Trial of Radical Pleurectomy and Post-Operative Chemotherapy With or Without Intraoperative Porfimer Sodium-Mediated Photodynamic Therapy for Patients with Epithelioid Malignant Pleural MesotheliomaPrincipal Investigator: Nwogu, Chukwumere E
(54767414MMY3010) An Open-Label Treatment Use Protocol for Daratumumab in Subjects with Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor and an Immunomodulatory Agent) or Are Double Refractory...Principal Investigator: Holstein, Sarah A
(ASTX727-01) A Phase 1-2 Pharmacokinetic Guided Dose-Escalation and Dose-Confirmation Study of ASTX727, a Combination of the Oral Cytidine Deaminase Inhibitor (CDAi) E7727 with Oral Decitabine in Subjects with Myelodysplastic Syndromes (MDS)Principal Investigator: Griffiths, Elizabeth A
An Expanded Access Program for Elotuzumab in Combination with Lenalidomide plus Dexamethasone in Patients with Relapsed or Refractory Multiple MyelomaPrincipal Investigator: Holstein, Sarah A
A Phase II, Multicenter, Three-Cohort Study of Oral cMET Inhibitor INC280 in Adult Patients with EGFR Wild-Type (wt), Advanced Non-Small Cell Lung Cancer (NSCLC) Who Have Received One or Two Prior Lines of Systemic Therapy for Advanced/Metastatic...Principal Investigator: Adjei, Alex
(SWOG S1203) A Randomized Phase III Study of Standard Cytarabine plus Daunorubicin (7+3) Therapy or Idarubicin with High Dose Cytarabine (IA) Versus IA with Vorinostat (IA+V) in Younger Patients with Previously Untreated Acute Myeloid Leukemia (AML)Principal Investigator: Wang, Eunice S
A Phase 1B Dose-Escalation and Phase 2A Study of TRC105 in Combination with Pazopanib in Patients with Advanced Soft Tissue SarcomaPrincipal Investigator: Boland, Patrick M
A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS15E Given as Monotherapy in Subjects with Metastatic Urothelial CancerPrincipal Investigator: George, Saby
A Phase I Open-Label Dose Escalation Study with Expansion to Assess the Safety and Tolerability of INC280 in Patients with c-MET Dependent Advanced Solid TumorPrincipal Investigator: Dy, Grace K
A Phase I/II Study of the HDAC Inhibitor LBH589 in Combination with the mTOR Inhibitor Everolimus (RAD001) in Metastatic Renal Cell CarcinomaPrincipal Investigator: George, Saby
(GOG 9923) A Phase I Study of Intravenous Carboplatin/Paclitaxel or Intravenous and Intraperitoneal Paclitaxel/Cisplatin in Combination with Continuous or Intermittent/CTEP-Supplied Agent ABT-888 (NSC# 737664) and CTEP-Supplied Agent Bevacizumab (...Principal Investigator: Lele, Shashikant B
(RU2612061) Randomized Phase II Study of AB (nab-paclitaxel [Abraxane], Bevacizumab) versus Ipilimumab for Therapy of Unresectable Stage IV Metastatic Malignant MelanomaPrincipal Investigator: Opyrchal, Mateusz
Principal Investigator: Ma, Wen Wee
Principal Investigator: Beaupin, Lynda K
(COG ACNS0332) Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET PatientsPrincipal Investigator: Fitzpatrick, Lorna
(NRG-GU001) Randomized Phase II Trial of Postoperative Adjuvant IMRT Following Cystectomy for pT3/pT4 Urothelial Bladder CancerPrincipal Investigator: Kuettel, Michael R
A Phase 3, Multicenter, Open-label, Randomized Study of SGI-110 versus Treatment Choice (TC) in Adults with Previously Untreated Acute Myeloid Leukemia (AML) Who Are Not Considered Candidates for Intensive Remission Induction ChemotherapyPrincipal Investigator: Griffiths, Elizabeth A
(COG ACNS1022) A Phase II Randomized Trial of Lenalidomide (NSC #703813, IND #70116) in Pediatric Patients with Recurrent, Refractory or Progressive Juvenile Pilocytic Astrocytomas and Optic Pathway GliomasPrincipal Investigator: Fitzpatrick, Lorna
Phase I Study of LBH589, A Novel Oral Deacetylase Inhibitor in Patients with Recurrent or Refractory Hodgkin or Non-Hodgkin's LymphomaPrincipal Investigator: Hernandez-Ilizaliturri, Francisco J
(COG AALL0932) Treatment of Patients with Newly Diagnosed Standard Risk B-Lymphoblastic Leukemia (B-ALL) or Localized B-lineage Lymphoblastic Lymphoma (B-LLy)Principal Investigator: Bambach, Barbara J
(RU021212I) Randomized Phase II Double Blind Study of Adjuvant Regorafenib vs Placebo in Patients with Node Positive Esophageal Cancer that Completed Pre-Operative TherapyPrincipal Investigator: Iyer, Renuka V
(BMT CTN 1203) A Multi-Center Phase II Trial Randomizing Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary ControlsPrincipal Investigator: Chen, George L
(COG ACNS1221) A Phase II Study for the Treatment of Non-Metastatic Nodular Desmoplastic Medulloblastoma in Children Less Than 4 Years of AgePrincipal Investigator: Fitzpatrick, Lorna
(COG ANBL1232) Utilizing Response- and Biology-Based Risk Factors to Guide Therapy in Patients with Non-High-Risk NeuroblastomaPrincipal Investigator: Higman, Meghan
(BMT CTN 1204) Reduced-Intensity Conditioning for Children and Adults with Hemophagocytic Syndromes or Selected Primary Immune Deficiencies (RICHI)Principal Investigator: Bambach, Barbara J
Phase I/II Study of Carfilzomib plus Rituximab plus Ifosfamide plus Carboplatin plus Etoposide (C-R-ICE) in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)Principal Investigator: Hernandez-Ilizaliturri, Francisco J
(KX02-01-13) A Phase 1 Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KX2-361 in Subjects with Advanced Malignancies that are Refractory to Conventional TherapiesPrincipal Investigator: Opyrchal, Mateusz
Filgrastim-Mobilized Peripheral Blood Stem Cells for Allogeneic Transplantation with Unrelated Donors (NMDP IRB 1996-005; IRB-1999-0021)Principal Investigator: McCarthy, Philip L
(C31001) A Phase 1b/2 Study of Safety and Efficacy of MLN0128 (Dual TORC1/2 Inhibitor) in Combination With Exemestane or Fulvestrant Therapy in Postmenopausal Women With ER+/HER2- Advanced or Metastatic Breast Cancer That Has Progressed on Treatme...Principal Investigator: Opyrchal, Mateusz
(M14-011) A Randomized, Placebo-Controlled, Double-Blind, Phase 3 Study Evaluating Safety and Efficacy of the Addition of Veliparib Plus Carboplatin Versus the Addition of Carboplatin to Standard Neoadjuvant Chemotherapy Versus Standard Neoadjuvan...Principal Investigator: Levine, Ellis G
Principal Investigator: Hahn, Theresa E
(BMT CTN Protocol 0702) Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients Who Have Enrolled on BMT CTN 0702Principal Investigator: Holstein, Sarah A
(COG AEWS1221) Randomized Phase II Trial Evaluating the Addition of the IGF-1R Monoclonal Antibody Ganitumab (AMG 479, NSC# 750008, IND# 120449) to Multiagent Chemotherapy for Patients with Newly Diagnosed Metastatic Ewing SarcomaPrincipal Investigator: Beaupin, Lynda K
(E1910) A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia in AdultsPrincipal Investigator: Wang, Eunice S
(NRG-CC002) Pre-Operative Assessment And Post-Operative Outcomes of Elderly Women with Gynecologic CancersPrincipal Investigator: Lele, Shashikant B
A Phase I/IIb Study of DEC205mAb-NY-ESO-1 Fusion Protein (CDX-1401) Given with Adjuvant Poly-ICLC in Combination with INCB024360 for Patients in Remission with Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma Whose Tumors Expres...Principal Investigator: Odunsi, Adekunle O
(CX-839-003) A Phase I Study of the Safety, Pharmacokinetics, and Pharmacodynamices of Escalating Oral Doses of the Glutaminase Inhibitor CB-839 in Patients with Relapsed and/or Treatment-Refractory LeukemiaPrincipal Investigator: Wang, Eunice S
(GOG 274) A Phase III Trial of Adjuvant Chemotherapy as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation alone: The OUTBACK trialPrincipal Investigator: Frederick, Peter
A Phase 2, Randomized, Multicenter Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase) Combined with nab-Paclitaxel Plus Gemcitabine Compared With nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Previously Untreated Pancreatic C...Principal Investigator: Ma, Wen Wee
Nab-Paclitaxel (ABRAXANEî) Plus Gemcitabine in Subjects with Locally Advanced Pancreatic Cancer (LAPC): An International, Open-Label, Multi-Center, Phase 2 Study (LAPACT)Principal Investigator: Ma, Wen Wee
Principal Investigator: Wang, Eunice S
Principal Investigator: Singh, Anurag K
Data Collection for Light Dosimetry and Treatment Planning Development for Photodynamic Therapy (PDT)Principal Investigator: Arshad, Hassan
(ALLIANCE A031201) Phase III Trial of Enzalutamide (NSC # 766085) Versus Enzalutamide, Abiraterone, and Prednisone for Castration Resistant Metastatic Prostate CancerPrincipal Investigator: George, Saby
Interstitial Photodynamic Therapy during Standard Chemotherapy for Palliation of Patients with Head and Neck Squamous Cell Carcinoma - Phase IIPrincipal Investigator: Arshad, Hassan
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) plus Modified FOLFOX 6 in Patients with Previously Untreated Metastatic Colorectal CancerPrincipal Investigator: Ma, Wen Wee
(ABI-007-PABC-003) A Phase 3, Multicenter, Open-Label, Randomized Study of nabî-PACLITAXEL Plus GEMCITABINE Versus GEMCITABINE Alone as Adjuvant Therapy in Subjects with Surgically Resected Pancreatic AdenocarcinomaPrincipal Investigator: Ma, Wen Wee
(STML-401-0214) A Phase 1/2 Study of SL-401 as Consolidation Therapy for Adult Patients with Adverse Risk Acute Myeloid Leukemia in First CR, and/or Evidence of Minimal Residual Disease (MRD) in First CRPrincipal Investigator: Wang, Eunice S
(COG AALL1231) A Phase III Randomized Trial Investigating Bortezomib (NSC# 681239; IND# 58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T-Lymphoblastic Leukemia (T-ALL) and T-Lymphobalstic Lymphoma (T-LLy)Principal Investigator: Bambach, Barbara J
(COG AHOD1331) A Randomized Phase III Study of Brentuximab Vedotin (IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and AdolescentPrincipal Investigator: Higman, Meghan
(BMT CTN 1101) Multi-center, Phase III, Randomized Trial of Reduced Intensity (RIC) Conditioning and Transplantation Of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow (Haplo) for Patients with Hematologi...Principal Investigator: McCarthy, Philip L
A Phase I/ II Trial of Pazopanib Alternating with Bevacizumab in Treatment-Naive Metastatic Clear Cell Renal Cell Carcinoma PatientsPrincipal Investigator: George, Saby
(CA209214) A Phase 3, Randomized, Open-Label Study of Nivolumab Combined with Ipilimumab Versus Sunitinib Monotherapy in Subjects with Previously Untreated, Advanced or Metastatic Renal Cell CarcinomaPrincipal Investigator: George, Saby
(ARO-006) A Safety and Tolerability Trial of Crenolanib and Chemotherapy with Cytarabine and Anthracyclines in Patients with Newly Diagnosed Acute Myeloid Leukemia with FLT3 Activating MutationsPrincipal Investigator: Wang, Eunice S
Principal Investigator: Boland, Patrick M
(GOG 0281) A Randomized Phase II/III Study to Assess the Efficacy of Trametinib (GSK 1120212) in Patients with Recurrent or Progressive Low-Grade Serous Ovarian Cancer or Peritoneal CancerPrincipal Investigator: Lele, Shashikant B
A Phase I Study Of CDK4/6 Inhibitor LEE011 Combined with Gemcitabine in Patients With Advanced Solid Tumors or LymphomaPrincipal Investigator: Adjei, Alex
A Phase II Study of the Safety and Efficacy of SVN53-67/M57-KLH (SurVaxM) in Survivin-Positive Newly Diagnosed GlioblastomaPrincipal Investigator: Fenstermaker, Robert A
(10112) Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Aged 60 or Older with HER2 Positive Locally Advanced or Metastatic Breast CancerPrincipal Investigator: O'Connor, Tracey L
Analysis of Analgesia Regimens during Concurrent Chemoradiation for Head and Neck Cancer: A Pilot StudyPrincipal Investigator: Singh, Anurag K
(GU12-160) A Randomized Phase 2 Study Comparing Docetaxel Alone to Docetaxel in Combination with OGX-427 in Patients with Relapsed or Refractory Metastatic Urothelial Carcinoma after Receiving a Platinum-containing RegimenPrincipal Investigator: George, Saby
Principal Investigator: Adjei, Alex
A Phase 1 Study to Evaluate the Safety and Tolerability of Anti-PD-L1, MEDI4736, in Combination with Tremelimumab in Subjects With Advanced Solid TumorsPrincipal Investigator: Odunsi, Adekunle O
A Dose-Regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oraxol in Subjects with Advanced MalignanciesPrincipal Investigator: Ma, Wen Wee
(S1400) Phase II/III Biomarker-Driven Master Protocol for Second Line Therapy of Squamous Cell Lung CancerPrincipal Investigator: Adjei, Alex
A Phase I/II Study of High Dose Interleukin 2, Aldesleukin, in Combination with the Histone Deacetylase Inhibitor Entinostat in Patients with Metastatic Renal Cell Carcinoma -Principal Investigator: George, Saby
FGFR1 Amplification as A Predictor of Efficacy in A Biomarker-Driven Phase II Study of BIBF 1120 in Advanced Squamous Cell Lung Cancer Patients Who Have Failed Up to Two Prior Chemotherapeutic RegimensPrincipal Investigator: Adjei, Alex
(BMT CTN 1102) A Multi-Center Biologic Assignment Trial Comparing Reduced Intensity Allogeneic Hematopoietic Cell Transplant to Hypomethylating Therapy or Best Supportive Care in Patients Aged 50-75 with Intermediate-2 and High Risk Myelodysplasti...Principal Investigator: McCarthy, Philip L
(NCI #9455) A Single Arm, Phase II Study of Single Agent Trametinib Followed by Trametinib in Combination with GSK2141795 in Patients with Advanced Triple Negative Breast CancerPrincipal Investigator: Levine, Ellis G
A Randomized Phase III Study Comparing Conventional Dose Treatment Using a Combination of Lenalidomide, Bortezomib and Dexamethasone (RVD) to High-Dose Treatment with Peripheral Stem Cell Transplant in the Initial Management of Myeloma in Patients...Principal Investigator: Holstein, Sarah A
Pilot Study to Analyze a Novel Mechanism Underlying Response to Tamoxifen Therapy in Breast Cancer PatientsPrincipal Investigator: Kumar, Shicha
(VS-6063-202) A Phase II Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of VS-6063 in Subjects with Malignant Pleural MesotheliomaPrincipal Investigator: Dy, Grace K
(BAY ONC-3012-036) A Phase II Single-Arm Study of Regorafenib Maintenance Therapy in Patients with T3, T4 or Node-Positive Rectal Cancer Patients who completed Curative-Intent TreatmentPrincipal Investigator: Ma, Wen Wee
Randomized Placebo-Controlled, Double-Blind Study Of Cholecalciferol Replacement in Patients on Expectant Management for Localized Prostate CancerPrincipal Investigator: Mohler, James L
Assessment of Tumor Cell Viability and Various Biomarkers from De-Identified Bladder Washing Samples Obtained From Patients with Bladder CarcinomaPrincipal Investigator: Guru, Khurshid
Reduced Burden of Oncologic Therapy in Advanced B-cell Lymphoma (REBOOT ABLY) in Children, Adolescents and Young Adults with CD20+ Mature B-Cell LymphomaPrincipal Investigator: Barth, Matthew J
(Alliance A221304) A Phase III Placebo-Controlled Randomized Three-Arm Study of Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without ChemotherapyPrincipal Investigator: Singh, Anurag K
A Phase 1b Dose Escalation Study of Vantictumab (OMP-18R5) in Combination with Docetaxel in Patients with Previously Treated Recurrent or Advanced Non-Small Cell Lung CancerPrincipal Investigator: Dy, Grace K
(A081105) Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)Principal Investigator: Dy, Grace K
Principal Investigator: Dy, Grace K
(E4512 )A Phase III Double-Blind Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib versus Placebo for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion ProteinPrincipal Investigator: Chen, Hongbin
(BMT CTN 1205) Easy to Read Informed Consent (ETRIC) for Hematopoietic Cell Transplantation Clinical TrialsPrincipal Investigator: Ross, Maureen
(E2112) A Randomized Phase III Trial of Endocrine Therapy plus Entinostat/Placebo in Postmenopausal Patients with Hormone Receptor-Positive Advanced Breast CancerPrincipal Investigator: Levine, Ellis G
A Dose-Regimen Finding Study to Evaluate Safety, Tolerability, Pharmacokinetics and Activity of Oratecan in Subjects with Advanced MalignanciesPrincipal Investigator: Ma, Wen Wee
Principal Investigator: Holstein, Sarah A
Principal Investigator: Wetzler, Meir
A Phase I Study of Ceritinib (LDK378), a Novel ALK Inhibitor, in Combination with Gemcitabine-Based Chemotherapy in Patients with Advanced Solid TumorsPrincipal Investigator: Ma, Wen Wee
(A041-04) A Phase 2 Randomized, Double -Blind Study of Dalantercept Plus Axitinib Compared to Placebo Plus Axitinib in Patients with Advanced Renal Cell CarcinomaPrincipal Investigator: George, Saby
Principal Investigator: Singh, Anurag K
(BAY 1129980/16044) An Open-Label Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability, Maximum Tolerated Dose, Pharmacokinetics, and Pharmacodynamics of the Anti-C4.4a Antibody Drug Conjugate BAY 1129980 in Subjects With Advanced So...Principal Investigator: Adjei, Alex
(SWOG S1202) A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor (AI)-Associated Musculoskeletal Symptoms in Women with Early Stage Breast CancerPrincipal Investigator: Levine, Ellis G
N1048 PROSPECT**) A Phase II/III Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality Chemoradiaiton Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection...Principal Investigator: Nurkin, Steven J
(Alliance A011106) ALTernate Approaches for Clinical Stage II or III Estrogen Receptor Positive Breast Cancer NeoAdjuvant TrEatment (ALTERNATE) in Postmenopausal Women: A Phase III StudyPrincipal Investigator: Levine, Ellis G
Ex Vivo Optical Imaging For Evaluation Of Tissue Obtained By Transbronchial Biopsies Of Peripheral Lung LesionsPrincipal Investigator: Harris, Kassem N
A Phase 1 Open Label, Multicenter, Multiple Ascending Dose Trial Evaluating the Safety, Tolerability and Immunogenicity of Intramuscular Recombinant NY-ESO-1 Protein with GLA-SE Adjuvant in Patients with Unresectable or Metastatic Cancer Expressin...Principal Investigator: Odunsi, Adekunle O
Feasibility of an Exercise Intervention to Enhance Fitness and QOL Among Adult Survivors of Childhood CancerPrincipal Investigator: Rokitka, Denise A
A Pilot Study of the Immunological Effects of Neo-Adjuvant INCB024360 in Patients with Epithelial Ovarian, Fallopian Tube or Primary Peritoneal CarcinomaPrincipal Investigator: Odunsi, Adekunle O
A Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 232 in Adult Subjects With Relapsed/Refractory Acute Myeloid LeukemiaPrincipal Investigator: Wang, Eunice S
Principal Investigator: Schwaab, Thomas
(A011202) A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 NI) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant ChemotherapyPrincipal Investigator: Levine, Ellis G
(COG ACCL1131) A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFI) Following Allogenetic Hematopoietic Cell Transplantation (HCT)Principal Investigator: Bambach, Barbara J
Principal Investigator: Schwaab, Thomas
Principal Investigator: Young, Jessica S
Principal Investigator: Erwin, Deborah O
(SWOG S1216) A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Hormone Sensitive Prostate CancerPrincipal Investigator: Levine, Ellis G
Multicenter Phase 1b/2 Study of Tivozanib in Patients with Advanced Inoperable Hepatocellular CarcinomaPrincipal Investigator: Iyer, Renuka V
A Phase I Study of Surgery Plus Intraoperative Photodynamic Therapy (PDT) with Temoporfin in Patients with Resectable Primary Non-Small Cell Lung Cancer (NSCLC) with Ipsilateral Thoracic Nodal (N1 or N2) or T3/T4 DiseasePrincipal Investigator: Nwogu, Chukwumere E
(COG ANHL1131) Intergroup Trial for Children or Adolescents with B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk PatientsPrincipal Investigator: Barth, Matthew J
(COG AALL1131) A Phase III Randomized Trial for Newly Diagnosed High Risk B-Precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC# 606869) in the Very High Risk StratumPrincipal Investigator: Bambach, Barbara J
(BMT CTN 1202) Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCTPrincipal Investigator: McCarthy, Philip L
(COG AAML1031) A Phase III Randomized Trial for Patients with de novo AML Using Bortezomib and Sorafenib (IND#114480; NSC#681239, NSC#724772) for Patients with High Allelic Ratio FLT3/ITDPrincipal Investigator: Beaupin, Lynda K
Impact of Carbonyl Reductase 3 Genotype Status on Echocardiographic Measurements of Cardiomyopathy in Breast Cancer Patients Treated with AnthracyclinesPrincipal Investigator: O'Connor, Tracey L
(COG ACNS0821) Temozolomide with Irinotecan Versus Temozolomide, Irinotecan Plus Bevacizumab (NSC# 704865, BB-IND# 7921) for Recurrent/Refractory Medulloblastoma/CNS PNET of Childhood, A COG Randomized Phase II Screening TrialPrincipal Investigator: Fitzpatrick, Lorna
A Phase II Study of Single Agent Topoisomerase-I Inhibitor Polymer Conjugate, Etirinotecan Pegol (NKTR-102), in Patients with Relapsed Small Cell Lung CancerPrincipal Investigator: Adjei, Alex
A Phase I Trial of a Recombinant Human hsp110-gp100 Chaperone Complex Vaccine for Advanced Stage IIIB/C or IV MelanomaPrincipal Investigator: Kane, John M
Principal Investigator: O'Connor, Tracey L
A Pilot Study of Stereotactic Body Radiation Therapy (SBRT) After TEMLA for Stage III and IV (Oligometastatic) Non-Small Cell Lung CancerPrincipal Investigator: Singh, Anurag K
Principal Investigator: Mahoney, Martin C
Influence of Advertising Claim Presentation on Beliefs and Affective Associations Related to Tobacco ProductsPrincipal Investigator: O'Connor, Richard J
A Pilot Study of the Flaxseed Effects on Hormones and Lignans: Role of Race, Genes, and Gut MicrobiomePrincipal Investigator: McCann, Susan E
Principal Investigator: Griffiths, Elizabeth A
Pilot: Impact of High-Dose, Single Fraction Radiation on Immunogenicity of Sipuleucel-T in Metastatic Castration Recurrent Prostate Cancer PatientsPrincipal Investigator: Schwaab, Thomas
Principal Investigator: Erwin, Deborah O
(COG ACNS0831) Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 YearsPrincipal Investigator: Fitzpatrick, Lorna
Correlation of Deuterated Phenanthrene Metabolism with Bronchoepitheial Dysplasia and Metaplasia in Smokers at High Risk for Lung CancerPrincipal Investigator: Adjei, Alex
Principal Investigator: Singh, Anurag K
Principal Investigator: Rokitka, Denise A
Plasma Mitochondrial DAMPs in Patients Receiving Chemotherapy or Allogenetic Hematopoietic Stem Cell TransplantationPrincipal Investigator: Segal, Brahm
Principal Investigator: Barth, Matthew J
(COG AEWS1031) A Phase III Randomized Trial of Adding Vincristine-Topotecan-Cyclophosphamide to Standard Chemotherapy in Initial Treatment of Non-Metastatic Ewing SarcomaPrincipal Investigator: Brecher, Martin
(CLR 10-23) A Phase I Pharmacokinetic and Safety Study of Paclitaxel Injection Concentrate for Nano-Dispersion (PICN) Alone and in Combination with Carboplatin in Subjects with Advanced Solid MalignanciesPrincipal Investigator: Ma, Wen Wee
KIR Genotyping for Unrelated Donor (URD) Selection Prior to Hematopoietic Cell Transplantation (HCT) for AML: Selecting a Favorable KIR DonorPrincipal Investigator: Ross, Maureen
Evaluation of Pre-Operative Nutritional Risk as a Predictor of Post-Operative Outcome in Patients Undergoing Robot-Assisted Radical CystectomyPrincipal Investigator: Guru, Khurshid
(COG AAML08B1) Biology Study of Transient Myeloproliferative Disorder (TMD) in Children with Down Syndrome (DS)Principal Investigator: Higman, Meghan
A Pilot Study Evaluating NFAT, NFkB and, ERK 1/2 Nuclear Translocation as a Predictive Marker for Acute Graft-versus-Host DiseasePrincipal Investigator: Chen, George L
Ofatumumab (O) in Combination With Chemotherapy: Hyper-Fractionated Cyclophosphamide, Doxorubicin, Vincristine and Dexamethasone (O-HyperCVAD) Alternating With Ofatumumab High-Dose Cytarabine and Methotrexate (O-MA) for Patients With Newly Diagn...Principal Investigator: Hernandez-Ilizaliturri, Francisco J
Randomized Phase II Study of Epigenetic Priming Using Decitabine with Induction Chemotherapy in Patients with Acute Myelogenous Leukemia (AML)Principal Investigator: Griffiths, Elizabeth A
(CIBMTR 10-CBA) A Multicenter Access and Distribution Protocol for Unlicensed Cryopreseved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other IndicationsPrincipal Investigator: McCarthy, Philip L
(COG ACCL0933) A Randomized Open-Label Trial of Caspofungin Versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)Principal Investigator: Bambach, Barbara J
(COG ACCL0934) A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT)Principal Investigator: Bambach, Barbara J
(SWOG S1007) A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 positive Nodes, Hormone Receptor-Positive and HER2-Negative Breast Cancer with Recurrence Score (RS) of 25 or lessPrincipal Investigator: Levine, Ellis G
Principal Investigator: Moysich, Kirsten B
Principal Investigator: Adjei, Alex
(CALGB 90203) A Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer -Principal Investigator: Mohler, James L
Intensity Modulated Radiation Therapy for Anal Cancer: Dosimetric Comparison, Acute Toxicity Profile, and Quality of Life AssessmentPrincipal Investigator: Mattson, David
Principal Investigator: Rokitka, Denise A
Principal Investigator: Hydeman, Jennifer A
Principal Investigator: Hong, Chi-Chen
Principal Investigator: Guru, Khurshid
Principal Investigator: Schwaab, Thomas
Genetic Signature for Progression of Barrett's Esophagus to Esophageal Adenocarcinoma. A Pilot StudyPrincipal Investigator: Bain, Andrew J
Principal Investigator: Voian, Nicoleta C
Principal Investigator: Reid, Mary E
(CALGB 140503) A Phase III Randomized Trial of Lobectomy Versus Sublobar Resection for Small (< 2 cm) Peripheral Non-Small Cell Lung CancerPrincipal Investigator: Nwogu, Chukwumere E
Principal Investigator: Rokitka, Denise A
Principal Investigator: Bambach, Barbara J
Principal Investigator: Rokitka, Denise A
Principal Investigator: Bansal Travers, Maansi
Collection of Blood from Healthy Donors and Patients with Non-Hodgkin's Lymphoma to Study the Immunological Activity of Peripheral Blood Mononuclear Cells (PBMC) and Human SerumPrincipal Investigator: Czuczman, Myron S
Principal Investigator: Hyland, Andrew J


text:
April 11, 2013
In case you've been living off the grid, the Specialty Coffee Association of America is hosting it's annual expo this week in Boston, MA. There'll be symposiums, the USBC, more barista competitions, new gear from the biggest names, networking, parties, and probably even a Sprudge puppet—a Spruppet—if everyone gets lucky.
If you can't be there like me, you can follow along on @sprudge, or just check out the hashtag #SCAA2013. There will be a lot going on, and it's sure to be a great time.
Today's doodle is inspired by all the fanfare and hooplah that surrounds the event, and features a Pirate Ship, a USBC staircase, and the city of Boston.


text:
After hearing of Klonoski's death, Hydorn said she went through her invoices to see whether she could find his written request. She could not find a letter from the name, Klonoski, but she did find a correspondence with an unclear recipient and address.
"It was a P.O. box," said Hydorn. "People can really give me any name they want. It could be Joe Blow and I wouldn't know the difference. I just have to trust people."
But Sen. Prozanski's office said the box sent to Klonoski, which was retrieved after his death, had his full name and home address written on the package. Hydorn's company, the Gladd Group, was clearly labeled as the sender of the package.
Hydorn also said that the Daily Beast insinuated that, along with her kit, she sends the recipient a copy of Final Exit, the how-to handbook for terminally ill people who wish to end their lives, written by Humphry. Hydorn said she does not sell the book, but Humphry told her that Klonoski had bought the book more than a year before he ended his life. Hydorn said many of her clients are referred by Humphry.
Frank Kavanaugh, a spokesman for Final Exit Network, said that the organization screens clients with physical and mental health exams to determine whether the network will help to supply information and counsel people on how to end their lives. Clients must be determined by a doctor to be in the last six months of their lives.
"One of the advantages of counseling is that, if a person makes it through preliminary checks, they're very carefully counseled to make sure what they're doing is successful," said Kavanaugh. "If you're not counseled, it can lead to a problem."
But, when asked whether Kavanaugh believes it is a problem that Hydorn does not screen her clients, he said: "I don't think she is being irresponsible. We don't have control of other people."
Some psychiatrists disagree. Dr. Eric Hollander, clinical professor of psychiatry and behavioral sciences at Albert Einstein College of Medicine in New York, said it is critical that individuals with psychiatric disorders resist acting on suicidal thoughts or impulses by helping them view their situation in a more realistic perspective.
"The problem is that with increased access to such a device to terminate life, some individuals might be enabled to act on a whim or impulse to kill themselves, whereas if this was not readily available, patients might obtain help for their underlying mental disorder, or view their situation from alternative or more realistic perspectives," said Hollander.
But Hydorn doesn't see it that way, and the grandmother wipes her hands free of repercussions after her kit is sent out.
"Again, if someone gets hurt, I'm sorry, but that's their decision," said Hydorn. "Somebody closer to them than me could have helped that person. It's not my responsibility to help emotionally sick people. There's local help for that."
Not In it for the Money
The Daily Beast reported that Hydorn makes $98,000 per year through her company, but she said that fact is wrong. "I have no idea where they got that number," said Hydorn.
Either way, Hydorn said she is not in it for the money.
"I get emotional satisfaction out of being able to help people," she said. "My motivation is to help people. If they misunderstand that, then so be it, but I'm not at fault for other people's choices."
If you or someone you know has contemplated suicide, please call theNational Suicide Prevention Lifeline at 1-800-273-8255. Lines are open 24 hours a day, 7 days a week.


text:
If you don't mind their trademark combination of foulness, expletives, poop jokes, and brilliant insight, I highly recommend this article on Cracked: Five Great Joys In Life That Healthy People Never Experience.
If you're lucky enough to have a condition that can be treated — not even cured, just treated a little — the moment the medication kicks in is like unlocking a secret level in life. All these years, you've existed at half power because chronic illness Harrison Bergeroned your ass, so any meds that take even a fraction of that weight off of your shoulders are basically giving you…superpowers. If people thought you were obnoxious after you got those glasses, with your constant prattle about wood grain and cloud patterns, they're going to strangle that newfound health right out of you the first time you wake up to find it doesn't hurt as much as it usually does.
"Holy sh★t, have you ever realized how great it is not to feel like you're going to die after you eat?"
"Have you tried this walking stuff? It's amazing! It hardly hurts at all!"
That's how I felt last night. I had 7 or 8 guys over for a poker game, old friends and new. It wasn't anything remarkable, except if you remember that I'm the guy who, five or ten years ago, would find it terrifying to even be in a room with 7 or 8 other men my age, forget about inviting them over.
A few drinks in and, thanks largely to having watched Warrior1 a few nights ago, I got the idea that after the game, wrestling would be a good idea. A lot of other people agreed, and we tore it up for a while — none of us particularly in shape, none of us knowing what we were doing, but everybody having a great time. We only smashed one lamp, but it wasn't even a nice lamp.
Hitting people and smashing things is, obviously, fun enough on its own, even before remembering that I'm the guy who, back in high school, faked a stomach illness because I was too terrified to participate in field day. And now I'm wrestling in my living room, in front of 7 other guys who are ALL CHEERING, and I'm not even worried about if I'm gonna win or how I'm gonna look? And not only that, but I don't do half bad?
I never would have believed it.
Like the guy on Cracked says, our condition is treatable. I'm not talking about SSA itself (the verdict is still out on that), but everything else, the stuff that really matters — the loneliness, the insecurity, the not-belonging.
The treatment is harder and slower than we'd like, but Oh man, it's worth it.


text: VANCOUVER, BC—Twenty organizations from across Canada have been named among the best-managed non-profit social service agencies nationwide and are in the running for $60,000 in prize money as finalists for the 13th annual Donner Canadian Foundation Awards for Excellence in the Delivery of Social Services."The Donner Awards honour Canadian non-profit organizations that maintain an unparalleled standard of excellence in the management and delivery of their services, despite the budgetary constraints all non-profit groups face," said Niels Veldhuis, Fraser Institute vice-president research. "By publicly celebrating the success of outstanding non-profit social service agencies, the Donner Awards seek to educate Canadians about the indispensable contributions these groups make to the well-being of individuals and communities nationwide."The Donner Awards are Canada's largest recognition program for non-profit social service agencies, established in 1998 to recognize and encourage best practices in non-profit management and increase public confidence and support for Canada's non-profit sector. The awards, administered by the Fraser Institute on behalf of the Donner Canadian Foundation, will be presented November 4th at a celebration in Toronto. Additional information is available at www.donnerawards.org.This year, 514 non-profit social service agencies from across Canada applied for the awards. Participating organizations are ranked on their performance in 10 key areas, including management and governance, the use of staff and volunteers, innovation, program costs, and outcome monitoring. The top organization in each of seven categories of social service delivery will be awarded $5,000, while the $20,000 William H. Donner Award for Excellence will be presented to the highest performer overall. In addition, the $5,000 Peter F. Drucker Award for Non-Profit Management will be presented to a non-profit organization with a consistent record of excellence and innovation in the management and delivery of services.2010 Donner Awards Finalists (by category) Counselling / Crisis Intervention


text:
There are only four days left to check out this amazing display of those Iowans who died for our freedom! The exhibit is on display at the Main Street Library (321 Main Street) through Tuesday, August 23! A video will be posted soon showing the opening ceremony this past Monday, August 15!
Iowa Fallen Soldier Exhibit at the Davenport Public Library through Tuesday, August 23!


text:
i really like the default pause/break hotkey for my desktop.
but i also have a netbook that doesn't have such a key, in which case i personally have used alt+backspace, and the ` character to trigger.
i wondered what other people use -- i know alt+space is common...
what do you use? do you have any custom FARR hotkeys set up to perform things like dictionary searches, etc.?


text:
If a girl broke up with Family Guy, it wouldn't be because it's too sensitive.The controversial Fox animated comedy has made a name for itself by being brash and daring, but others would deem it callous and crass. Whatever you call it, creator
Fox's Batman prequel Gotham will have no shortage of Easter eggs in the coming weeks as the show...
In a cringe-worthy interview on CNN's State of the Union Sunday, Mike Huckabee compared...
American Sniper took in an additional $31.8 million this weekend, making it the No. 1 movie at...
Whitney Houston's daughter
Justin Timberlake and
Saturday Night Liveput forth its strongest show of the season this weekend, with host
One night last December, 22-year-old Dominique Harrison-Bentzen came out of a nightclub in Preston, England, and discovered she didn't have money for a taxi home. She also didn't have her bank card, and her cell phone battery was dead. She was...
[WARNING: The following story contains spoilers from Saturday's episode of Black Sails. Read at your own risk.]Look who's back!Saturday's episode of
Move over, marinara.
Creamy casseroles, sans the calories.
- Events Calendar


text:
"....if there is activity in the ball prior to the rubbing action....
Bill Belichick, Sat Jan 24, 2015
"You may think that you are some kind of god to these people. But we both know what you really are."
"What's that? A criminal?"
"Worse. A politician."
Source: Under The Dome
Sent from my DROID Pro using Tapatalk 2
We like to claim first rights to everything but English can not be one. As a matter of fact in the eyes of an Oxford English speaking person the American English sounds dumb and uneducated. Our English is merely a rip-off of the English language which has established itself over a few hundred years.
We have no right to place judgement on another country's version of the English language. This whole notion that black people can't speak English will be thrown out of the window if you have ever heard a black English person speaking in its finest Oxford English. And he sounds so smart but we really don't know if he actually is smart.
If an English person in the US says: Yesterday I smoked five fags. Are you suing him for discrimination or hate crime against gays? Because after all "smoking five fags" could be translated as 'beating up on 5 homosexual people' not "smoking five cigarettes".
This whole PC crap is going overboard nowadays.
What difference DOES it make? There are people who make their living "race-baiting". No racism means no job so they have to find it or create it.
It is a fact that at one time whites around the world treated non-whites very poorly. Therefore, anything that rich white descendants of slave owners think/consider/ponder or do in respect to non-whites IS racist. People who were white in the USA and what was to become the USA between 30-400 years ago were racist so whites must be racist now. It is safe for these people to assume that those who control Volkswagen are white because rich descendants of slave owners would never allow non-whites to rise to a position of power in the company - because their racist - a fact supported by circular logic that there likely aren't many minorities in the Volkswagen board room.
Attachment 9768
Im somewhat disappointed that more African Americans dont think for themselves and just go with whatever theyre supposed to say and think."
- Dr. Benjamin Carson


text:
Terms & Conditions.
Some product exclusions may apply. See product page details for more information. Clearance items are final sale. Price matching does not apply to this or any promotion. Offer is valid until September 13 at 11:59 PM PST. May not be combined with any other offer/discount (unless specified), including invitation credits, promotional gift cards and/or special discount links. Discount applied upon checkout. Log in to your account to see your savings.
Getting dressed in the AM is no easy feat—it's messy, it's time consuming, and looking chic is never as simple as those fashionistas on the street style blogs make it out to be. But this black velvet cape turns the nightmare-inducing task into something actually enjoyable. Pair this strong silhouette with skinny jeans and tall boots for casual weekdays or toss it over your LBD for a chic evening look.
Bust 36"–38". Shoulder width 18". Length 50.5". Sleeves 15". This gently used vintage garment is in good condition. Shows some signs of age.
This product has no reviews yet. Be the first to review this product. Write a review
Enjoy 10% off your first order*


text:
The Lost World of Genesis One
Walton presents and defends twenty propositions supporting a literary and theological understanding of Genesis 1.
The Resource Finder has powerful filtering features — check out the tutorial to learn more.
Walton presents and defends twenty propositions supporting a literary and theological understanding of Genesis 1.
Philosopher Robert Bishop explores the Biblical doctrine of creation, which he describes as "perhaps one of the most helpful pieces of theology for thinking about science", and describes why the doctrine needs to be recovered from narrower, contemporary interpretations of creation.
Science and Religion scholar Denis Alexander presents two models for relating Adam and Eve with the findings of contemporary anthropology. This essay was presented at the November 2010 Theology of Celebration Workshop
"As a Christian and a biblical scholar, I care both about Scripture as truth and about the ongoing scholarly conversation regarding the composition of the Hebrew Scriptures. And so, when I was asked to speak on the story of creation in Genesis 1, I welcomed the opportunity to give my thoughts on the interaction between this text and its ancient Near Eastern context."
Professor Denis Lamoureux presents the theory of evolutionary creation, which claims that the Father, Son, and Holy Spirit created the universe and life through an ordained, sustained, and design-reflecting evolutionary process. The view of origins, says Lamoureux, fully embraces both the religious beliefs of biblical Christianity and the scientific theories of cosmological, geological, and biological evolution.
Lucidly and eloquently written, it is a work of the heart that helps us not only to understand deeply God's Word in its context, but also to consider how it applies to us today. -Amazon


text:
Lacking most of the skull, with the heart and other organs protruding from his tiny body, Elliot Josiah Henderson never really had a chance.
Guided by faith, his mother firmly believed she never really had a choice but to bear a son whose two-hour life outside the womb seven years ago Monday represents an especially gut-wrenching aspect to an issue that already divides the nation along medical, moral and political lines.
"(The doctor) said I had the option of abortion, but there was no way I could dismember and extract my baby," said Karla Henderson, a 33-year old mother of three who got her first inkling something was wrong when an ultrasound during the sixth week of gestation revealed an abnormal pocket of blood on her uterine wall. Serious deformities were evident by the 14th week and by the 20th week the fatal diagnosis had been rendered, but Henderson said the decision she and husband Mike made to embrace "perinatal hospice" has nevertheless blessed her family and others confronted by similar challenges.
Why would a woman knowingly carry a child who could not survive a vaginal birth (Elliot was delivered by Caesarian section after 36 weeks) and whose life would be measured in hours if not minutes?
"I chose to surrender to (God's) plan, which is perfect even if it's not what we would choose," Henderson said. "Life has value – every life. I don't know how people could go through this without God."
Some people will dismiss the Hendersons as religious zombies unable or unwilling to deal with reality or their own feelings. But the stay-at-home Mom and her 37-year-old husband of 12 years, an Allen County Police officer, experienced everything from pain and anger to confusion about God and dissatisfaction with each other.
"I needed (Mike) to be my girlfriend," Karla said, alluding to the male tendency to internalize concerns instead of verbalizing them.
But when they sat in their dimly lit room at Parkview Hospital and held each other and their infant son before his heart slowed then finally stopped, the Hendersons were at peace.
"We knew it would be tough, but it was the right thing to do and brought us closer together," Mike said.
"It was the hardest choice I ever made," confessed Karla, who acknowledged for a time not wanting to bond with the baby in her womb following the diagnosis. But when she did embrace the pregnancy, the couple set aside the name they subsequently gave their now-3-year-old son Brecken and substituted a name Karla said means "the Lord is good who heals."
And part of that healing, Karla said, is the absence of the guilt the couple would have felt had they denied Elliot the brief period during which his life was much like any other newborn infant's.
"He even pooped three times," she said.
Abortion vexes this country precisely because it resists easy compromise. Women's-rights advocates refuse to acknowledge the humanity of the "fetus," just as many on the other side believe mere mortals lack the wisdom or right to end life God has begun. But when birth defects assure a short life or a long life of misery and expense or are used to justify what under other circumstances would be considered euthanasia, what then?
Still, if women do indeed have the "right to choose," the kind of agonizing decision made by the Hendersons and those inspired by them deserve respect and at least an attempt at understanding.
Unfortunately, the medical personnel who were sympathetic to the Hendersons' decision may be the exception instead of the rule, according to Cathie Humbarger, executive director for Allen County Right to Life.
"The assumption in the medical community seems to be that it is best to terminate (this kind of pregnancy), Humbarger said. But that can be excruciatingly painful for the baby, and (giving birth) can be a better outcome for the mother."
To that end, a free seminar is scheduled at the downtown library this week to educate social workers, medical personnel, members of the public and others about the case for "continuing a pregnancy with life-limiting prenatal diagnosis." Panelists will include a doctor, ethicist, pastor, counselor and others. They will make some convincing arguments, but you don't have to be a pro-abortion zealot to understand opposing views.
There are no shades of gray for the Hendersons, however, which is why this week and every November Mike, Karla, Bennett, Brecken and daughter Delancey visit Elliot's grave – a son and brother rendered no less real, loved or mourned by the hardship and brevity of his life.


text:
Judith Cramer-Fendelman
Professional Background
Educational Background
Scholarly Interests
"Judith Cramer discusses the relation of New Media with 'The Levees' Curriculum" (2007). Link to the audio podcast. on iTunes U.
Selected Publications
Crocco, M., Cramer, J., & Meier, E.B. (2008). (Never) mind the gap! Gender equity in social studies research on technology in the twenty-first century. Multicultural Education & Technology Journal, 2(1), 19–36.
Cramer, J., Boxer, D. & Neil, D. (2007). In our own image: Using representations of Katrina to empower media-literate citizens. In M. S. Crocco (Ed.), Teaching The Levees: A curriculum for democratic dialogue and civic engagement (pp. 25-40). New York: Teachers College Press.
Cramer, J. (2005). Blogs in the machine. In R. Diem & J. Passe (series Eds.) & M.S. Crocco (Vol. Ed.), Social studies and the press: Keeping the beast at bay?, (pp. 199-211).
Crocco, M. & Cramer, J. (2005). Women, WebQuests and controversial issues in the social studies. Social Education 69(3), 143-148.
Crocco, M. & Cramer, J. (2005). Women, technology use, and global studies in social studies teacher education. Contemporary Issues in Technology and Teacher Education, 5(1), 38–49. Available at: http://www.citejournal.org/vol5/iss1/socialstudies/article1.cfm
Cramer, J. (2004) To blog or not to blog? A WebQuest for teachers of high school journalism and English. Available at: http//:www.columbia.edu/~jc1427/BlogQuest.html
Crocco, M. & Cramer, J. (2004). A virtual hall of mirrors? Confronting the digital divide in urban social studies teacher education. Journal of Computing in Teacher Education, 20(4), 133-139.
Cramer, J. & Scharf, E. (2002). Desktop poetry project. Learning & Leading with Technology, 29(6), 28-31, 50-51.
professional presentations
Teaching The Levees: Inscribing Realities Through Documentary Film and Curriculum. (April, 2008). National Council of Teachers of English/ Conference on College Composition and Communication (NCTE/CCCC), New Orleans, LA.
Teaching The Levees: Students as Media Literate Citizens. (March, 2008). Half-day workshop, Computer Using Educators (CUE), Palm Springs, CA,
Teaching "The Levees": Stimulating Democratic Dialogues on Race and Class. (March, 2008). Panel, Association for Supervision and Curriculum Development (ASCD), New Orleans, LA.
Teaching the Levees: What Kind of Country Are We? What Do We Want to Be? (February, 2008). Half-day workshop, National Association of Independent Schools (NAIS), New York, NY.
Teaching the Levees. (November, 2007). Interactive panel, People of Color Conference (PoCC), Boston, MA.
Gender, Technology and the Social Studies: Outlook for a New Century (April, 2007). Paper, American Educational Research Association (AERA), Chicago, IL.
Language Learning for a Small Planet: The Pocket Lab. (March, 2007). National Association of Independent Schools (NAIS), Denver, CO.
Using the Web to Support Field Trips (November, 2006). New York State Association for Computers and Technologies in Education (NSYCATE), Rochester, NY.
"WeMedia": Simple Technology Tools Empower Students as Citizen Journalists. (November 2006). New York State Association for Computers and Technologies in Education (NSYCATE), Rochester, NY.
Gender, Technology and the Social Studies: What's the Problem? (March, 2006). Panel, Society for Information Technology & Teacher Education (SITE), Orlando, FL
Virtual Museum: A WebQuest. (May, 2005). Half-day workshop, New York City Museum Educators Roundtable (NYCMER) Annual Conference, Museum of Modern Art, New York, NY.
Instructional Strategies that Promote Critical Thinking: Proving Technology's Effectiveness. (June, 2004). Half-day workshop, National Educational Computing Conference (NECC), New Orleans, LA.
(Re)Imagining Technology in the Humanities Classroom: HISTORY to histories. (May, 2004). Half-day workshop, Metropolitan School Study Council (MSSC) Spring Conference, New York, NY.
Women, Technology Use, and Global Studies. (March, 2004). Full Paper, Society for Technology & Teacher Education (SITE), Atlanta, GA, with Dr. Margaret Crocco, Teachers College. Best Paper Award. Available at: http://www.citejournal.org/vol5/iss1/socialstudies/article1.cfm
Desktop Poetry Project. (November, 2003). National Council of Teachers of English (NCTE), San Francisco, CA.
Tools for Teaching Histories. (May and December, 2003). iEARN CIVICS Seminars for Teachers from Primarily Muslim Nations, New York, NY.
L.A.N. for Learning. (February, 2002). Midwest Educational Technology Conference, St. Louis, MO.
"We Media" Curriculum Project Grant, Office of Diversity & Community, Office of the President, Teachers College,
Technology Artist-in-Residence Grant,
Technology Partners: A Project Approach to Pre-Service Technology Infusion, US Department of Education PT3 Grant, 2000-2004. PT3 Visiting Team Leader,
Crossing Digital Divides in Humanities Education, PT3 Grant Proposal, US Department of Education, 2001 (unfunded)
The URBS Curriculum in Classics and Computer Science, National Endowment for the Humanities Grant Proposal, 2000 (unfunded)
Greenberg Grant for Writing and Critical Thinking,
Documents & Papers
Download: Flickr Instructions Admin (PDF) [PDF]
Download: Flickr Instructions Admin
Download: Flickr Instructions Sets (PDF) [PDF]
Download: Flickr Instructions Sets
Download: Flickr Instructions Students (PDF) [PDF]
Download: Flickr Instructions Students


text:
Call us toll-free
Picture your brand visible at homes and desks everywhere, with great selection of Bulk Picture Frames! We offer a great variety of styles from leather, plastic, digital and metal custom picture frames all at prices your business can afford.
5" x 7" Aluminum Photo Frames
New Style & Lower Price! Display your company logo beautifully on this stylish brushed aluminum frame. It holds a 5" x 7" picture and your choice of top or bottom imprint locations. Photo frames make for picture perfect promotions.
From: $3.87 | Min Qty: 100 | Production Time: 3 Days
Essentials™ 4" x 6" Courbure I Aluminum Photo Frame
Make a great impression with these fantastic Curved Aluminum Photo Frames. These lovely frames will hold your favorite 4 x 6" photo. Curved Photo Frames provide an elegant background for your logo or message making your thoughtful gift notable.
From: $4.07 | Min Qty: 100 | Production Time: 5 Days
4" x 6" Bamboo Photo Frames
For an eco-friendly promotion worth framing, order these bamboo photo frames to showcase your logo. The 4 x 6 photo frame is constructed out of all natural bamboo making it a welcome addition to any office or home.
From: $9.25 | Min Qty: 60 | Production Time: 1 Days
4" x 6" Madison Leather Photo Frames by LEEMAN
A picture perfect promotion is in store with these elegant black leather photo frames. The Madison is from the Leeman Collection and is made of cowhide leather with silver contrasting. Showcases your logo in silver and its 5 x 7 photos.
From: $16.43 | Min Qty: 25 | Production Time: 5 Days
|Images are not necessarily shown in proportion to other products.
|Images are not necessarily shown in proportion to other products.


text:
Vonn wins in Are to secure Overall
Lindsey Vonn won the first of the regular season Giant Slalom's in October and she won the last of the World Cup Giant Slalom's as well. The win not only meant that she goes into the World Cup Finals having secured her fourth Overall Globe as well but it also means that the Giant Slalom Globe is still up for grabs as well. The superlatives on Vonn continue as she has also surpassed her own personal record points total for a single season, she now has 1808 points with five races left in the season.
Vonn won the first run in spring like conditions and while others were struggling and losing time, Vonn managed to extend her lead at the top of the second run and then kept her relentless pace up to the finish. With Federica Brignone from Italy taking second, Viktoria Rebensburg, leader in the Giant Slalom standings was left back in third, losing 40 points to Vonn on the day. Anna Fenninger took fourth equal in the race.
"I don't know what to say, I just wanted to have two really aggressive runs today," said Vonn, who today tied her previous record of 11 wins in one season. "I have nothing to lose. I'm just having fun, my sister is here, my teammates are so cool cheering me on in the finish."
This, the 52nd win of Vonn's career puts her just two behind another HEAD legend, Hermann Maier and three behind Vreni Schneider who is third in the All Time list of race wins. Janica Kostelic's Women's all time points record of 1970 is under serious threat in the remaining five races.
Vonn admitted to being nervous before the second run and paid tribute to her teammates for providing the information about the course on her second run. "I was a bit cautious on the second run on various points," she admitted.
Anna Fenninger placed fourth for the 7th time in her career and said afterwards: "In Ofterschwang it was just because I was angry about the hundredth. This time it was incredibly hard, the blows were extreme. This result is already in the past."
1. Lindsey Vonn (USA) HEAD
2. Federica Brignone (ITA)
3. Viktoria Rebensburg (GER)
4. Anna Fenninger (AUT) HEAD


text:
Home > Pet Supplies > Leashes, Collars, & Apparel > Dog Leashes > Safety Glo Solar/USB Rechargeable Lighted Dog Leash
Safety Glo Solar/USB Rechargeable Lighted Dog Leash
SafetyGlo - Keeping you and your pet safe.
Why SafetyGlo?
You're walking your dog at night. A car speeds by. You see them, but they don't see you. As a dog owner, dangerous close calls like this will happen. That's why there's SafetyGlo, the only USB and Solar Rechargeable Leash on the market. SafetyGlo emits a bright glowing light visible from over 500 yards away, keeping you and your pet seen and safe.
- No Batteries Needed - Eco-Friendly Lithum ion LIR2032 power pack is included. Rechargeable by solar rays or USB connectivity (power cable included)
- Superior Visibility - Bright, Visible LED Strips. Lights can be operated in a steady or flashing mode
- Quality - Durable, multi-stitched Nylon combined with the latest technology to create a superior product
- SafetyGlo's adjustable leash will accommodate any size pet!
- Power - Cell lasts for 5 hours of continuous use - charge in as little as 45 minutes!
- Product Materials: Durable, Multi stitched Nylon; LED'sBattery Type: NA
Safety Glo Solar/USB Rechargeable Lighted Dog Leash
Reviewed by 1 customer
- Attractive Design
- Durable
- Easy To Assemble
- nice weight
- none
Best Uses
- Outdoors
- Walks
Comments about Safety Glo Solar/USB Rechargeable Lighted Dog Leash:
Solar or USB charging
- I Am A:
- Single Male
Safety Glo Solar/USB Rechargeable Lighted Dog Leash
Our innovative products will provide you and your family with years of enjoyment. And with the Brookstone Protection Plus service and replacement plans, you'll have the added peace of mind knowing that if the unexpected does happen, we will simply repair or replace your covered product. Our enhanced coverage goes above and beyond the manufacturer's warranty, saving you time and money.
Shopping Cart


text:
Through CrossRoads, we encourage students to explore the purposes of our lives, our gifts and abilities, and our directions for the future. It's about our "callings"—something that applies not just to ministers and a few others, but to people in all walks of life.
Not just jobs but callings
Our programming is designed to help us all to think theologically about careers, callings and life. Woven throughout your education—from the First-Year Seminar to Residence Life programs and Senior Seminar—this kind of thinking ties together career planning, faith concerns and professional preparation.
Through this process, you identify how your future work in a specialized field of study can meet the world's most pressing needs. Although this process is by no means limited to students interested in ministry, we do offer special CrossRoads Scholarships for young people who will become the new leaders of the diverse, multicultural church of the future.
"Studying religion at Hope has introduced me to a larger conversation in which one can be a world-class scholar and remain a faithful Christian." Jeffrey Skaff '10, 2009–2010 Lilly Scholar
Working with great minds
CrossRoads helps make it possible for you to learn from professors whose own faith tradition ranges from Evangelical to Roman Catholic, and who place themselves on a wide spectrum from theological liberal and theological conservative. The result? Open-minded, respectful discussions that deepen your understanding beyond the "sound bite," and that give you the intellectual tools to analyze complex issues and grow in self-understanding.
With CrossRoads support, Hope faculty have integrated a concern for service into courses in economics, management and accounting, and Hope Professor Michelle Bombe led students through a week's exploration of how they felt called to use their talent in the theatre. Our goal is to cultivate your aspirations, help you set goals and support your achievement.
[1] http://www.hope.edu/admissions/christian-character/the-crossroads-project


text:
This download contains one car from the February American Le Mans Series pack: 2011 Volkswagen Polo GTI. In game credits or Car Tokens required to purchase this car in Career Play. The complete February American Le Mans Series pack contains ten cars, including: 2011 Audi #2 Audi Sport North America R18 TDI, 1986 Audi #2 Audi Sport quattro S1, 2011 Bentley Platinum Motorsport Continental GT, 2010 Dodge Quinton "Rampage" Jackson Challenger SRT8. The February American Le Mans Series pack is also available for purchase.
Click to create and send a link using your email application


text:
The great thing about this poster is that it features three great NHL players of the 1990s - including two of the top centers in the world today. Ron Hextall, like him or not, was one of the top goaltenders of the past decade. Joe Sakic, along with Peter Forsberg, makes the Avalanche a perennial top-five team. Mats Sundin is the franchise in Toronto, and was the MVP of Sweden's 1998 World Championship team.
This poster has a real classic look to it. It is part of the short-lived "Team Leaders" series that Starline quickly scuttled after one year. The appearance of three hockey greats on one poster, in the uniform of a now-defunct team, makes this poster a true collector's item.
Product Specifications:


text:
Terms & Conditions.
Some product exclusions may apply. See product page details for more information. Clearance items are final sale. Price matching does not apply to this or any promotion. Offer is valid until September 13 at 11:59 PM PST. May not be combined with any other offer/discount (unless specified), including invitation credits, promotional gift cards and/or special discount links. Discount applied upon checkout. Log in to your account to see your savings.
Need a wallet? Of course you do…everyone does. This one, from Vernakular, is made from genuine leather and is thinly lined in a printed fabric. It features multiple card slots and a zippered pocket in the middle for change—or anything else you'd like to keep hidden (don't worry, we won't tell). But what really sets this wallet apart from all others is that it's got art on it. Printed with a photograph by Neil Ryder Hoos, we'd say this wallet is right on the money!
Photograph taken in New York City. Wallet measures 8.2" x 3.5", open.
Please note: As the wallet ages, the image may fade. This gives it a distinct worn-in, vintage look.
This product has no reviews yet. Be the first to review this product. Write a review
Enjoy 10% off your first order*


text:
As a kid in New Hampshire, Jennifer Hill fantasized about the locales of her father's business trips. Armed with a degree in design, history, and printmaking, she toyed with color and pattern at Fresh beauty company before opening JHill Design in Boston in 2005. Inspired by dayd
This product has no reviews yet. Be the first to review this product. Write a review
Enjoy 10% off your first order*


text:
Follow Me On:
Major Pettigrew's Last Stand
Welcome and thank you for visiting my web site. While it was often a struggle to write this first novel, it was never hard to spend time in the company of Major Pettigrew. From the first time he opened the door to his home, Rose Lodge, he has always seemed to live and be real - and my biggest challenge has been not to let him down by failing to tell his story. I hope you enjoy meeting him too.
Helen Simonson
In the noisy world of today it is a delight to find a novel that dares to assert itself quietly with the lovely rhythm of Helen Simonson's funny, comforting and intelligent debut...
Elizabeth Strout,
Pulitzer Prize-winning author of Olive Kitteridge
|Major Pettigrew's Last Stand is now a New York Times Bestseller!
As the Major and Mrs. Ali discover just how much they have in common, including an educated background and a shared love of books, they must struggle to understand what it means to belong and how far the obligations of family and tradition can be set aside for personal freedom. Meanwhile, the village itself, lost in its petty prejudices and traditions, may not see its own destruction coming.
See Helen Simonson talk about Major Pettigrew's Last Stand and read an excerpt.
"Major Pettigrew has it all,"
- New York Times
"slow burning pleasure,"
- Times of London
"delightful debut"
- O Magazine
"Crisp wit and gentle insight"
- Washington Post
"vastly enjoyable,"
- Publishers Weekly


text:
- New
- Gifts
- Seasonal
- Household
- Organizers
- Kitchen
- Health & Beauty
- Lawn & Garden
- As Seen on TV
- Sale
- More Ways to Shop
- Web Exclusives
- College Living
- Bed & Bath
- Apparel
- Entertainment
- Home Decor
- Pets
- Weekly Specials
- Military Offer
"Fanny" bank makes saving money a real GAS! Just drop a coin in the strategically-placed slot of this tushy-shaped bank and listen as it lets out the loudest rip you've ever heard. Add more loot, hear more toot! Up to six flatulent sound effects, guaranteed to make you laugh your "assets" off! Coins remove easily when bank is full. 6" H x 6". Uses 3 AA batteries (not incl.)
Welcome to Harriet Carter - Distinctive Gifts Since 1958. Find a large selection of products for organizing your life, as well as As Seen On TV products, household gadgets and problem solvers, unique gifts and gift ideas. Buying online is the fastest and most convenient way to shop! We have created this website just for you; everything is arranged by product category for quick, easy selection. In addition to our selection of gift ideas, you'll find products for organizing, As Seen On TV items, New Arrivals, Web Exclusive Gifts, Household Gadgets and products for your Pets.
Copyright 2015 Harriet Carter Gifts, Inc.
All Rights Reserved.
Harriet Carter
We are now accepting PayPal as a form of payment. For those of you unfamiliar with PayPal, it is a Web-based service that enables you to pay an online merchant without revealing your financial information. We've added this payment option to better meet your expressed needs for confidence, control, convenience and choice in your payment methods.
Learn more about PayPal and decide if you would like to set up a PayPal account.
Thanks for visiting our Web site - come back soon!


text:
July 24
Wednesday, 5:00 - 8:00 pm
P.M. @ Penn Museum Summer Nights Concert
Cold Blue Electric
This exciting four-piece jazz/fusion ensemble presents an eclectic repertoire of classic jazz, '70s and '80s fusion hits, stylish progressive rock, and their own unique original material. Visit www.reverbnation.com/coldblueelectricfusion for more information.
Tickets are just $5 each, and include Museum admission donation. For more information, call 215.898.2680.
See below for a video of a Cold Blue Electric jam session.
3260 South Street
Philadelphia, PA 19104
(215) 898-4000
Tuesday-Sunday: 10:00am - 5:00pm
First Wednesdays: 10:00am - 8:00pm
Monday: CLOSED


text:
Re: Goooood Morning SHR - Monday
It's currently 33* here at 10:16 AM & will only get one more degree higher for the day.
Going to have snow showers in the afternoon into eve & windy. News on TV this morn said this eve the roads will be slick so a winter advosory will be posted.
Radar is quite colorful, light greens, pinks, & blue knocking on our door. But the radar in motion on the weather channel's web site freezes up before it gets done. Had been doing this last few days. They must be updating it or something? Anyway, not a good weather day for us.
"We know that Mother Nature is a woman. If she were a man, there would be no rain on race day."


text: Lindane has been targeted for a ban by the U.S. Environmental Protection Agency (EPA) since 1977, but has somehow managed to stay on the market. Meanwhile more than 50 countries have banned this dangerous chemical. What are the forces behind the survival of this old and dangerous pesticide in the U.S.?


text:
In one of the least surprising moves, Williams have confirmed that Valtteri Bottas will replace Bruno Senna for the 2013 season...
In one of the least surprising moves, Williams have confirmed that Valtteri Bottas will replace Bruno Senna for the 2013 season.
The 23-year-old Bottas, who has made several Friday practice appearances for the Grove-based squad this year, will race alongside Pastor Maldonado.
"In Pastor and Valtteri we have two of the most exciting talents in motor racing and I am especially excited about what 2013 can bring for Williams," said team boss Sir Frank Williams.
"Pastor has always demonstrated remarkable pace and this year has seen him mature as a racing driver. Valtteri is quite simply one of the most talented young racing drivers I have come across and we expect great things from him in the future. I would also like to take this opportunity to thank our departing driver Bruno Senna for his hard work over the past year and wish him the best of luck going forward.''
Bottas won the 2011 GP3 Championship and spent the past three seasons as Williams' test driver.
''It has always been my life-long dream to compete in the Formula One World Championship," the Finn said.
"To do so with one of the most legendary teams in the sport is incredibly special. I've really enjoyed my three years with Williams so far and feel very at home here so my goal was always to stay for 2013 and progress to a race seat. I'm looking forward to getting my Formula One career started and enjoying a lot of success with Williams.''


text:
St. Petersburg, FL (Sports Network) - Stephen Drew's grand slam capped an eight-run third inning which propelled Boston over Tampa Bay by a 9-2 count in the second edition of a three-game series from Tropicana Field.
Dustin Pedroia, David Ortiz, Mike Napoli and Jonny Gomes each added an RBI during the onslaught, while Will Middlebrooks hit a late solo homer for the Red Sox, who put the brakes on a three-game skid.
Jon Lester (6-0) worked seven solid innings, giving up eight hits and two runs with five strikeouts. The 29-year-old lefty hasn't lost since Sept. 26, 2012 in a start at Fenway against Tampa, and hasn't dropped a road decision since Sept. 16 of last season at Toronto.
Desmond Jennings hit an RBI triple and Ben Zobrist also knocked in a run for the Rays, whose season-high six-game win streak came to an end.
David Price (1-4) departed after just 2 1/3 frames with tightness in his left triceps, but not before he was tagged for five hits and four runs. Jamey Wright subbed for the reigning AL Cy Young winner, but surrendered the other four BoSox runs in the inning.
The Sox exploded in their third turn at the plate. Drew opened the frame with a walk, then Jacoby Ellsbury singled. After Shane Victorino flied out, Pedroia and Ortiz slugged back-to-back RBI singles for a 2-0 game which signaled Price's exit due to injury.
Wright came on but served up a run-scoring double from Napoli and an RBI single from Gomes. He retired Middlebrooks but walked Jarrod Saltalamacchia before Drew barely cleared the wall in right for a grand slam and 8-0 lead.
"No excuses, I just stunk tonight," Wright said. "I threw two sinkers right down the middle. One got hit for a double and one got hit up the middle. Then a cutter into Drew, I tried to go up and in and I threw it right down and in right into his swing path. He hit a home run. It was awful. I didn't do my job out there today."
A Jennings triple and Zobrist groundout cut Tampa's deficit to six in the home third, but the Rays fell silent from there.
Middlebrooks' solo homer in the eighth gave Boston a 9-2 advantage and capped the rout.
"Finally, we broke out with the eight runs in one inning," Red Sox manager John Farrell said. "It gave us some cushion to allow Lester to go out and pitch. More than anything, for our guys to go up and swing with some freedom, take some at-bats with some confidence. A good night offensively, particularly in the one inning."
Jon Lester improved to 4-1 (9 earned runs) and has 45 strikeouts in 36 innings
over his last six starts at Tropicana Field since the start of 2009 ... Coming
into the game, Lester's 2.17 ERA in Tampa leads all pitchers with at least
four starts at the Trop ... Price has not won on his home field since
July 19, 2012, a span of eight starts.
© 2015 Ramar Communications |
Site Map |
Terms Of Use |
Privacy Statement |
Copyright & Trademark Notice |
EEO Report |
FCC Public Files |
Closed Captioning |


text:
In modern times, most people have come to realize the importance of a generator, whether it is for the home, office, corporation or elsewhere. At the same time, however, it is often essential that the generator noise is kept to a minimum. Most people simply do not want to bear the loud noise of a running machine. That goes for home owners, neighbors, campers and so on.
Above you will find a variety of quiet generators to choose from. If you are looking to quiet the generator you already have you may want to invest in a muffler kit. You can find our mufflers by searching the word "muffler" in the key word search up at the top or by going to the home page under accessories. Otherwise, feel free to browse the items above and find a selection of our quiet generators for sale.


text:
Description: 2.2GHz Xeon 512K CPUHewlett-Packard Part# 301019-001
HP Processor Kits:
Manufacturer Part# 301019-001
This is the full processor option kit. It includes the
Processor(s), Heat-Sink(s), Fan(s), Thermal paste
and VRM (Voltage Regulator Module) where required.
Overview:Do you and your business need the most powerful and new computer? Almost surely you do. There's an effective and affordable way to harness the power of the newest processors and you'll not empty your pockets. In order to satisfy the demands of its customers Hewlett-Packard offers a variety of processor upgrade options thus eliminating the need of purchasing new computers. You can choose the processor upgrade that suites ideally your computer and your budget.
CategoryProliant Processor
Part Number301019-001
Products ID141308
Product TypeProcessor Upgrade
Processor TypeXeon
Product TypeProcessor Upgrade
Clock Speed2.2 GHz
L2 Cache Size512 KB
ApplicationML350 G3
Heat SinkIncluded
Voltage Regulator Module (VRM)Included
[ Replacement Video ]


text:
We are experiencing unprecedented levels of new economic development in our City. The resurgence of downtown has created ample reason to be optimistic about Rochester's future.
We also have a unique opportunity to increase the economic landscape and improve the quality of life within our neighborhoods.
Successfully capitalizing these opportunities requires innovative approaches that leverage our resources to benefit as many of our residents and businesses as possible.
If there ever was a time to contribute to the vitality of Rochester, that time is now. I encourage you to invest in our City's future – be it your time, talent, or treasure – and help us make Rochester one of the best mid-sized cities to live, work, and play.
The Neighborhood and Business Development Department's goal is to provide safe, healthy neighborhoods, create thriving commercial corridors, increase economic vitality in underserved areas, assist and develop industry, and create jobs for its citizens. We use a team-oriented approach with our residents, investors and community partners to solve problems, address quality of life concerns, support our businesses and enhance our neighborhoods through helpful and courteous customer service.
If you would like additional information, please feel free to contact the Commissioner's Office at (585) 428-6883.
Baye' MuhammadCommissioner of NBD
The City of Rochester, NY is an Equal Opportunity Employer. | Fair Housing | Terms of Use | Accessibility | Privacy | Security | Contact Us | Video Tour